Shuh Narumiya Selected Research

Shuh Narumiya Research Topics

Disease

58	Inflammation (Inflammations) 01/2022 - 04/2002
24	Neoplasms (Cancer) 12/2022 - 01/2002
10	Pain (Aches) 05/2011 - 07/2003
9	Contact Dermatitis (Eczema, Contact) 10/2019 - 06/2003
8	Fever (Fevers) 01/2017 - 09/2003
8	Asthma (Bronchial Asthma) 11/2016 - 04/2002
8	Stroke (Strokes) 10/2012 - 03/2007
7	Intracranial Aneurysm (Cerebral Aneurysm) 01/2019 - 01/2014
7	Carcinogenesis 07/2015 - 01/2002
6	Wounds and Injuries (Trauma) 04/2022 - 10/2006
6	Ischemia 01/2020 - 11/2003
6	Infarction (Infarctions) 10/2012 - 03/2007
6	Brain Ischemia (Cerebral Ischemia) 10/2012 - 03/2007
5	Alzheimer Disease (Alzheimer's Disease) 03/2015 - 11/2007
5	Fibrosis (Cirrhosis) 07/2012 - 09/2003
5	Hypersensitivity (Allergy) 07/2011 - 08/2003
5	Hyperalgesia 05/2011 - 07/2003
4	Infections 01/2022 - 08/2008
4	Rheumatoid Arthritis 09/2020 - 02/2006
4	Atopic Dermatitis (Atopic Eczema) 11/2019 - 08/2003
4	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 03/2016
4	Hypertension (High Blood Pressure) 08/2019 - 01/2005
4	Neoplasm Metastasis (Metastasis) 12/2015 - 10/2006
4	Ischemic Stroke 01/2014 - 03/2009
4	Brain Injuries (Brain Injury) 01/2014 - 01/2009
4	Colonic Neoplasms (Colon Cancer) 10/2006 - 01/2002
4	Hypertrophy 07/2005 - 06/2002
3	Colitis 08/2020 - 04/2002
3	Immune System Diseases (Immune Disorders) 10/2019 - 01/2010
3	Necrosis 10/2019 - 11/2009
3	Dermatitis 01/2018 - 10/2013
3	Reperfusion Injury 01/2018 - 05/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2003
3	Pathologic Processes 03/2016 - 08/2008
3	Melanoma (Melanoma, Malignant) 12/2015 - 01/2008
3	Edema (Dropsy) 02/2014 - 03/2013
3	Gliosis 01/2014 - 04/2006
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2014 - 12/2009
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2012 - 03/2007
3	Vascular Remodeling 10/2011 - 03/2010
3	Tachycardia (Tachyarrhythmias) 02/2011 - 11/2003
3	Cardiomegaly (Heart Hypertrophy) 02/2011 - 11/2003
3	Atherosclerosis 02/2011 - 09/2004
3	Disease Progression 07/2010 - 12/2009
2	COVID-19 01/2022 - 04/2021
2	Demyelinating Diseases (Demyelinating Disease) 11/2020 - 04/2006

Drug/Important Bio-Agent (IBA)

78	ProstaglandinsIBA 01/2022 - 01/2002
29	Dinoprostone (PGE2)FDA Link 01/2022 - 11/2003
19	Prostaglandins EIBA 07/2012 - 01/2002
17	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 08/2020 - 01/2002
13	Prostaglandin D2IBA 01/2022 - 04/2002
11	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2018 - 10/2002
11	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2012 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2002
9	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
9	CytokinesIBA 01/2019 - 09/2003
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 07/2002
8	Prostaglandin Receptors (Prostaglandin Receptor)IBA 05/2011 - 04/2002
7	ThromboxanesIBA 01/2022 - 01/2004
7	Prostaglandins DIBA 04/2021 - 06/2002
7	AntigensIBA 10/2019 - 06/2003
7	ChemokinesIBA 01/2019 - 03/2010
7	Epoprostenol ReceptorsIBA 01/2018 - 09/2004
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 01/2002
7	EnzymesIBA 07/2015 - 09/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014 - 01/2004
4	LipidsIBA 12/2022 - 02/2003
4	LigandsIBA 12/2022 - 02/2007
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 07/2002
4	Dextrans (Dextran)FDA Link 08/2020 - 04/2002
4	Indomethacin (Indometacin)FDA LinkGeneric 11/2019 - 07/2003
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017 - 09/2005
4	Thromboxane Receptors (Thromboxane Receptor)IBA 07/2015 - 09/2004
4	salicylhydroxamic acid (SHAM)IBA 01/2014 - 04/2007
4	prostaglandin F2alpha receptorIBA 10/2013 - 01/2009
3	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2019
3	prostaglandin D2 receptorIBA 01/2022 - 08/2014
3	EicosanoidsIBA 01/2022 - 01/2008
3	Pharmaceutical PreparationsIBA 04/2021 - 07/2003
3	Arachidonic Acid (Vitamin F)IBA 08/2019 - 08/2003
3	Interleukin-23 (Interleukin 23)IBA 01/2019 - 08/2010
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 06/2014
3	HaptensIBA 01/2018 - 10/2009
3	Prostaglandin-E SynthasesIBA 01/2017 - 12/2015
3	AzoxymethaneIBA 01/2017 - 01/2002
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017 - 04/2013
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 04/2002
3	Interleukin-6 (Interleukin 6)IBA 07/2015 - 02/2006
3	SaltsIBA 01/2014 - 01/2005
3	Prostaglandins FIBA 10/2012 - 05/2005
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2012 - 11/2007
3	4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA 02/2010 - 04/2002
2	lysophosphatidic acidIBA 12/2022 - 10/2005
2	asapiprantIBA 01/2022 - 04/2021
2	Phospholipases (Phospholipase)IBA 01/2022 - 12/2009
2	Immunoglobulin E (IgE)IBA 11/2019 - 09/2003

Therapy/Procedure

7	Therapeutics 01/2022 - 12/2009
4	Chemoprevention 01/2017 - 02/2005
3	Ligation 08/2019 - 01/2014